Cellebrite CFO sells 41,734 shares for RSU taxes

Cellebrite DI Ltd. Chief Financial Officer David Barter reported an open-market sale of 41,734 ordinary shares at a weighted average price of $16.3756 per share.

Rhea-AI Filing Summary

Cellebrite DI Ltd. Chief Financial Officer David Barter reported an open-market sale of 41,734 ordinary shares at a weighted average price of $16.3756 per share. The filing states the shares were originally granted as RSUs on July 7, 2025 and that the disposition is associated with tax obligations related to their vesting.

After the transaction, Barter directly holds 334,219 ordinary shares. The price reflects multiple trades between $16.21 and $16.62 per share.

Insider Trade Summary

Net Seller: 41,734 shares

Net Sell 1 txn

Insider Barter David

Role Chief Financial Officer

Sold 41,734 shs ($683K)

Type	Security	Shares	Price	Value
Sale	Ordinary shares, par value NIS 0.00001	41,734	$16.3756	$683K

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 334,219 shares (Direct)

Footnotes (2)

1. F1. The shares reported as disposed herein were granted on July 7, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.21 to $16.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 41,734 shares Weighted average sale price: $16.3756 per share Post-transaction holdings: 334,219 shares +2 more

5 metrics

Shares sold 41,734 shares Open-market sale on July 8, 2026

Weighted average sale price $16.3756 per share Ordinary shares, multiple trades

Post-transaction holdings 334,219 shares Direct ownership after sale

Price range of trades $16.21–$16.62 per share Range for individual executions

RSU grant date July 7, 2025 Grant date of underlying RSUs

Key Terms

restricted stock units ("RSUs"), weighted average price, open-market sale, tax obligations

4 terms

restricted stock units ("RSUs") financial

"The shares reported as disposed herein were granted on July 7, 2025, in the form of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

tax obligations financial

"The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cellebrite (CLBT) CFO David Barter report in this Form 4?

Cellebrite CFO David Barter reported selling 41,734 ordinary shares in an open-market transaction. The sale relates to shares granted as RSUs and is associated with tax obligations triggered when those RSUs vested, according to the filing footnotes.

How many Cellebrite (CLBT) shares did the CFO sell and at what price?

The CFO sold 41,734 ordinary shares at a weighted average price of $16.3756 per share. Footnotes explain these were multiple trades executed between $16.21 and $16.62, with full price breakdowns available on request from the company or regulators.

How many Cellebrite (CLBT) shares does the CFO hold after this transaction?

After the reported sale, the CFO directly holds 334,219 ordinary shares of Cellebrite. This figure shows his remaining equity position following the transaction and helps investors gauge the sale’s scale relative to his continuing ownership stake.

Were the Cellebrite (CLBT) CFO’s sold shares related to RSUs or open-market purchases?

The sold shares were originally granted as restricted stock units (RSUs) on July 7, 2025. The filing states the disposition is associated with tax obligations arising from the vesting of those RSUs, rather than from ordinary open-market purchases by the executive.

What does the weighted average price mean in this Cellebrite (CLBT) Form 4?

The weighted average price of $16.3756 reflects many individual trades between $16.21 and $16.62. Instead of listing each execution, the filing provides an average and notes that detailed per-trade information is available to the issuer, holders, or SEC staff upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/09/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barter David

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	07/08/2026		S		41,734(1)	D	$16.3756(2)	334,219	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported as disposed herein were granted on July 7, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.21 to $16.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ David Barter	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)